These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8296708)
1. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure. Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans. Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713 [TBL] [Abstract][Full Text] [Related]
3. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure. Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976 [TBL] [Abstract][Full Text] [Related]
4. Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure. Keller N; Sykulski R; Larsen J Clin Physiol; 1991 May; 11(3):199-210. PubMed ID: 1832602 [TBL] [Abstract][Full Text] [Related]
5. Prolonged hemodynamic benefits from a high-dose bolus injection of human atrial natriuretic factor in congestive heart failure. Giles TD; Quiroz AC; Roffidal LE; Marder H; Sander GE Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):557-63. PubMed ID: 1834391 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Marcus LS; Hart D; Packer M; Yushak M; Medina N; Danziger RS; Heitjan DF; Katz SD Circulation; 1996 Dec; 94(12):3184-9. PubMed ID: 8989127 [TBL] [Abstract][Full Text] [Related]
7. Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure. Herrmann HC; Palacios IF; Dec GW; Scheer JM; Fifer MA Am Heart J; 1988 Jun; 115(6):1232-8. PubMed ID: 2967626 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819 [TBL] [Abstract][Full Text] [Related]
9. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure. Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045 [TBL] [Abstract][Full Text] [Related]
11. Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure. Keller N; Sykulski R; Thamsborg G; Storm T; Larsen J Clin Physiol; 1988 Feb; 8(1):57-64. PubMed ID: 2964972 [TBL] [Abstract][Full Text] [Related]
12. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation. Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923 [TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure. Moe GW; Canepa-Anson R; Armstrong PW J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766 [TBL] [Abstract][Full Text] [Related]
14. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker. Sanderson JE; Chan WW; Hung YT; Chan SK; Shum IO; Raymond K; Woo KS Br Heart J; 1995 Nov; 74(5):502-7. PubMed ID: 8562234 [TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure]. Fontana F; Guardigli G; Cappelli M; Bernardi P G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692 [TBL] [Abstract][Full Text] [Related]
16. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure. Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure. Münzel T; Drexler H; Holtz J; Kurtz S; Just H Circulation; 1991 Jan; 83(1):191-201. PubMed ID: 1845857 [TBL] [Abstract][Full Text] [Related]
19. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Aaser E; Gullestad L; Tølløfsrud S; Lundberg J; Hall C; Djøseland O; Kjekshus J; Forfang K Scand J Clin Lab Invest; 1997 Jul; 57(4):361-7. PubMed ID: 9249883 [TBL] [Abstract][Full Text] [Related]
20. Effects of long-term infusion of synthetic atrial natriuretic factor on hemodynamics and water input-output balance in patients with acute myocardial infarction. Nakamura M; Arakawa N; Yoshida H; Funakoshi T; Aoki H; Hiramori K Jpn Heart J; 1993 Nov; 34(6):707-16. PubMed ID: 8164338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]